You are here: Industry Insights > Takeda

News List

Takeda partners with Cardurion Pharma biospectrumasia
August 07, 2017
Takeda will jumpstart the new company’s discovery efforts by providing a 12-person cardiovascular research team from its Shonan, Japan site.
Takeda, Molecular Templates Announce Multi-Target Research, Licensing Collaboration americanpharmaceuticalreview
August 04, 2017
Takeda and Molecular Templates announced a collaboration agreement for oncology drug discovery programs.
Takeda and Cardurion Form Cardiovascular Partnership contractpharma
August 04, 2017
Collaboration to develop novel, next-generation therapeutics to treat heart disease
Takeda and Prana to research neurodegeneration treatment for Parkinson's disease pharmaceutical-technology
July 20, 2017
Takeda Pharmaceuticals International has entered a new research collaboration to study the ability of Prana Biotechnology’s investigational movement disorders compound...
Takeda and Biological E. collaborate to develop affordable combination vaccines pharmaceutical-technology
June 28, 2017
Japanese pharmaceutical company Takeda has entered two licensing agreements with Indian firm Biological E. to accelerate the development and supply of low-cost combination vaccines.
Takeda, Biological E ink pact to develop and commercialize vaccines biospectrumasia
June 28, 2017
As per the terms, BE has rights to use Takeda's measles vaccine technology for a combination MR vaccine, pertussis vaccine technology for any pertussis-containing combination vaccine
Swissmedic accepts review of Takeda and TiGenix’s file on Cx601 pharmaceutical-technology
June 28, 2017
The Swiss Agency for Therapeutic Products (Swissmedic) has accepted a review of Takeda and TiGenix’s file on investigational compound Cx601 for the treatment of complex perianal fistulas in patients with Crohn's disease.
Takeda, Seattle Genetics' Adcetris hits main goal of late-stage study as front-line treatment for Ho firstwordpharma
June 27, 2017
Takeda, Seattle Genetics' Adcetris hits main goal of late-stage study as front-line treatment for Hodgkin lymphoma
Takeda and BE collaborate expressbpd
June 27, 2017
To develop low-cost vaccines for low and middle-income countries
Takeda completes new manufacturing facilities at the Oranienburg site in Germany cphi-online
June 23, 2017
The manufacture of solid dosage form pharmaceutical products would be transferred from the Osaka Plant to the new plant.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page